智翔金泰:2025年度业绩快报

Core Viewpoint - Zhixiang Jintai announced that it expects to achieve a total operating revenue of 230,722,204.02 yuan in 2025, representing a year-on-year growth of 666.65% [2] Financial Performance - The net profit attributable to the parent company's owners is projected to be -536,220,722.04 yuan, with losses narrowing by 32.74% year-on-year [2]

Chongqing Genrix Biopharmaceutical -智翔金泰:2025年度业绩快报 - Reportify